Al-Modawat Specialized Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	74.42	74.31	58.57	40.84
Revenue Growth (YoY)	5.65%	26.88%	43.41%	-
Cost of Revenue	38.12	33.93	30.71	26.17
Gross Profit	36.3	40.37	27.85	14.67
Selling, General & Admin	19.33	15.67	14.13	15.56
Other Operating Expenses	-	-	-	-0.42
Operating Expenses	22.16	18.5	15.71	15.14
Operating Income	14.15	21.88	12.14	-0.48
Interest Expense	-1.13	-1.13	-0.69	-0.22
Other Non Operating Income (Expenses)	0.37	0.04	-0.52	-
EBT Excluding Unusual Items	13.39	20.78	10.92	-0.69
Other Unusual Items	-1.33	-1.33	-0.31	-
Pretax Income	12.05	19.45	10.61	-0.69
Income Tax Expense	1.21	0.85	0.33	0.03
Earnings From Continuing Operations	10.85	18.59	10.28	-0.73
Net Income	10.82	18.59	10.31	-2.21
Net Income to Common	10.82	18.59	10.31	-2.21
Net Income Growth	-38.53%	80.28%	-	-
Shares Outstanding (Basic)	21	19	19	-
Shares Outstanding (Diluted)	21	19	19	-
Shares Change (YoY)	8.72%	-	-	-
EPS (Basic)	0.52	0.98	0.54	-
EPS (Diluted)	0.52	0.98	0.54	-
EPS Growth	-43.46%	80.28%	-	-
Free Cash Flow	-4.09	9.68	2.32	-2.26
Free Cash Flow Per Share	-0.20	0.51	0.12	-
Dividend Per Share	0.840	0.700	-	-
Gross Margin	48.78%	54.33%	47.56%	35.92%
Operating Margin	19.01%	29.44%	20.73%	-1.17%
Profit Margin	14.54%	25.02%	17.61%	-5.40%
Free Cash Flow Margin	-5.50%	13.03%	3.96%	-5.53%
EBITDA	16.06	23.62	13.69	0.93
EBITDA Margin	21.58%	31.79%	23.37%	2.29%
D&A For EBITDA	1.92	1.74	1.55	1.41
EBIT	14.15	21.88	12.14	-0.48
EBIT Margin	19.01%	29.44%	20.73%	-1.17%
Effective Tax Rate	10.02%	4.39%	3.09%	-
Advertising Expenses	-	0.16	0.08	-

Source: S&P Capital IQ. Standard template. Financial Sources.